prof. dr. E.M.D. (Ed) Schuuring

Field/Discipline

• Pathology
• Oncology
• Medicine, Research & Experimental

Expertise

Other positions

• Head of the Laboratory for Molecular Pathology at the UMCG
• Senior Clinical Scientist in Molecular Pathology (Klinisch Moleculair Bioloog in de Pathologie)
• Clinical Scientist in Molecular Pathology for Stichting Pathologie Friesland in Leeuwarden, Martini Ziekenhuis in Groningen, Pathologie Treant Zorggroep Bethesda Hospital in Hoogeveen and ADCNV lab in Curacao
• Official instructor for educating and training of KMBP (clinical scientist in molecular pathology)
• Member (past-president) of section Clinical Molecular and Experimental Pathology of the Dutch Society of Pathology
• Member of the committee on “Revision of Onco-guidelines for NSCLC” (2019-2020)
• Member of the committee on cervical cancer primary hrHPVpopulation-based screening program and responsible Clinical Scientific in Molecular Pathology for quality at UMCG screeningcenter
• Active member of board in PATH and COIN programs
• Senior expert/advisor on Molecular Pathology for ZIN/VWS, insurrance-companies, missiePTO, IKNL-platform CUP
• Member of committee cieBOD (commissie BeOordeling Diagnostiek)
• Member Redactieraad of Esculaap Media bv Journal in Dutch “Longkanker”
• Referent for LongkankerNederland, KankerNL and Thuisarts websites with information for patients regarding DNA testing in cancer patients
• Between 2012-2020 (31-12-2020): from commercial partners he received honoraria for expertise or scientific advisory board/consultancy (on request): MSD/Merck, AstraZeneca, Roche, Pfizer, Novartis, Bayer, BMS, Lilly, Amgen, Qiagen, BioCartis, Illumina, Agena Bioscience, CC Diagnostics, QCMD, ESP, IQNPATH, Cancer-ID, Janssen Cilag (Johnson&Johnson), Diaceutics; Speaker’s fee from Agena Bioscience, Bio-Rad, Abbott, Novartis, Roche, Biocartis, Illumina, Pfizer, Astrazeneca; Grants/Sponsoring from Abbott, MDXHealth/Oncomethylome, Pfizer, Biocartis, Cancer-ID, BMS, Astrazeneca, Invitae/Archer, Bayer, Bio-Rad, Roche, Agena Bioscience, CC Diagnostics, Boehringer Ingelheim, Qiagen, Promega, TATAA (all above-mentioned fee transferred to UMCG); Travel reimbursements from Agena Bioscience, BioRad, Illumina, Abbott, Roche and Hologic.
• Bestuurslid van cieKNT (commissie Klinisch Noodzakelijke Targets)
• Bestuurslid van cieTripartite
• Member of European Society of Pathology (ESP), member ESP-workinggroup Molecular Pathology, member of ESP/QUip (QC-ringstudies on NSCLC and cfDNA (2012-now)
• Executive board member of European Liquid Biopsy Society, co-lead of ELBS-ctDNA workinggroup
• Bestuurslid (en mede-oprichter) van NVVP-registratiecommissie voor KMBPio (2011-2025)
• Executive board member (and founder) of the European Master Molecular Pathology